Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaginal Sildenafil for Primary Dysmenorrhea
NCT07508358Phase 1Not yet recruiting
- Start
- Oct 2026
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of sildenafil in dysmenorrhea. Primary endpoint: Change from baseline in number of uterine contractions at 4 hours. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
sildenafil
03
Conditions
dysmenorrhea
Beyond the preview
Go deeper on NCT07508358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07508358.